The effect of environmental tobacco smoke on the dose requirements of rocuronium in children

Paediatric Anaesthesia

Volumn 14, Issue 3, 2004, Pages 247-250

  Reisli, Ruhiye ^a   Apilliogullari, Seza ^a   Reisli, Ismail ^a   Tuncer, Sema ^a   Erol, Atilla ^a   Okesli, Selmin ^a  

^a SELCUK UNIVERSITY   (Turkey)

Author keywords

Anaesthesia; Passive smoking; Rocuronium; Tobacco smoke pollution

Indexed keywords

NITROUS OXIDE; OXYGEN; ROCURONIUM; SEVOFLURANE; TOBACCO SMOKE;

ANESTHESIA INDUCTION; ARTICLE; CHILD; CONTROLLED STUDY; DOSE RESPONSE; ELECTROMYOGRAPHY; ENVIRONMENTAL EXPOSURE; EVOKED MUSCLE RESPONSE; FEMALE; HUMAN; MALE; MONITOR; NEUROMUSCULAR BLOCKING; NORMAL HUMAN; PASSIVE SMOKING; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SMOKING;

ANDROSTANOLS; ANESTHESIA, GENERAL; CHILD; CHILD, PRESCHOOL; ELECTROMYOGRAPHY; FEMALE; HUMANS; MALE; NEUROMUSCULAR BLOCKADE; NEUROMUSCULAR NONDEPOLARIZING AGENTS; TOBACCO SMOKE POLLUTION;

EID: 1642380469     PISSN: 11555645     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9592.2003.01186.x     Document Type: Article

References (13)

1. Miller LG. Cigarette and drug therapy: pharmacokinetic and pharmacodynamic considerations. Clin Pharm 1990; 9:125-135.
2. Miller LG. Recent developments in the study of the effects of cigarette smoking on clinical pharmacokinetics and clinical pharmacodynamics. Clin Pharmacokinet 1989; 17: 90-108.
3. Dawson GW, Vestal RE. Smoking and drug metabolism. Pharmacol Ther 1982; 15: 207-221.
4. Rang HP, Dale MM, Ritter JM. (eds) Drug dependence and drug abuse. In: Pharmacology 4th edn. Edinburgh: Churchill Livingstone, 1999: 618-623.
5. Puura AIE, Rorarius MG, Laippala P et al. Does abstinence from smoking or a transdermal nicotine system influence atracurim-induced neuromuscular block? Anesth Analg 1998; 87(2): 430-433.
6. Teiria H, Rautoma P, Yli-Hankala A. Effects of smoking on dose requirements for rocuronium. Br J Anaesth 1996; 76: 154-155.
7. Rautoma P, Svartling N. Smoking increases the requirement for rocuronium. Can J Anaesth 1998; 45(7): 651-654.
8. Puhringer FK, Keller P, Lockinger A et al. Smoking does not alter the dose-requirements and the pharmacodynamics of rocuronium. Can J Anaesth 2000; 47(4): 347-349.
9. Koop CE. Adverse anesthesia events in children exposed to environmental tobacco smoke: exposure to environmental tobacco smoke and risk of adverse respiratory events in children receiving general anesthesia. Anesthesiology 1998; 88(5): 1141-1142.
10. Skolnick ET, Vomvolakis MA, Buck KA et al. Exposure to environmental tobacco smoke and risk of adverse respiratory events in children receiving general anesthesia. Anesthesiology 1998; 88(5): 1144-1153.
11. Lakshmipathy N, Bokesch PM, Cowan DE et al. Environmental tobacco smoke: a risk factor for pediatric laryngospasm. Anesth Analg 1996; 82(4): 724-727.
12. Latorre F, de Almeida MC, Stanek A et al. The effect of smoking on neuromuscular transmission after rocuronium. Anaesthesist 1997; 46(6): 493-495.
13. Kroeker KA, Beattie WS, Yang H. Neuromuscular blocade in the setting of chronic nicotine exposure. Anesthesiology 1994; 81: A1120.